{"id":16489,"date":"2023-04-24T05:47:29","date_gmt":"2023-04-24T05:47:29","guid":{"rendered":"https:\/\/d36deud6t4mnhi.cloudfront.net\/?page_id=16489"},"modified":"2024-11-15T10:56:53","modified_gmt":"2024-11-15T08:56:53","slug":"governance","status":"publish","type":"page","link":"https:\/\/www.ipsen.com\/sustainability\/governance\/","title":{"rendered":"Governance"},"content":{"rendered":"    <section class=\"sub-page-banner bg-img\" style=\"background-image:url(https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/13164309\/Module-1-%E2%80%93-banner_Governance-Responsibility_1920x280pix.png)\">\n        <div class=\"container content-sec\">\n            <nav aria-label=\"breadcrumb\">\n            <ol class=\"breadcrumb\">\n                <li class=\"breadcrumb-item\"><a href=\"https:\/\/www.ipsen.com\">Home<\/a><\/li><li class=\"breadcrumb-item visible\"><a href=\"https:\/\/www.ipsen.com\/sustainability\/\">Sustainability<\/a><\/li><li class=\"breadcrumb-item active\" aria-current=\"page\">Governance<\/li><\/ol>\n            <\/nav>            <h1 class=\"visible\">Governance<\/h1>\n            <p class=\"visible\"><\/p>\n        <\/div>\n    <\/section>\n\n\n\t<!-- Hero Carousel Start Here-->\n\t<section class=\"hero-section blue-filter\">\n\t\t<div class=\"hero_gridwidth container\"><!-- container class shown if gridlayout choosen -->\n\t\t\t<div id=\"heroCarousel\" class=\"carousel slide herocaro hero-banner-bg-image\" data-bs-ride=\"carousel\" data-enableplaybtn=\"1\" data-autoplay= \"\"  data-autospeed= \"\" >\n\t\t\t\t<!-- Slider Indicator-->\n\t\t\t\t<div class=\"carousel-indicators hidden\">\n\t\t\t\t<button type=\"button\" data-bs-target=\"#heroCarousel\" data-bs-slide-to=\"0\" class=\"active\" aria-current=\"true\" aria-label=\"Slide 0\"><\/button>\t\t\t\t<\/div>\n\t\t\t\t<!-- Items -->\n\t\t\t\t<div class=\"carousel-inner\">\n\t\t\t\t\t\t\n\t\t\t\t\t\t<!-- Hero Banner with carousel HTML -->\n\t\t\t\t\t\t<div class=\"carousel-item active\">\n\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img decoding=\"async\" class=\"bd-placeholder-img visible\" width=\"100%\" height=\"100%\" src=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2024\/10\/08131728\/Module-2-Hero-image_Acting-with-integrity-and-responsibility_1980x720pix.jpg\" aria-hidden=\"true\" title=\"Hero Banner\" alt=\"Hero Banner\" \/> \n\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\n\n\t\t\t\t\t\t\t<div class=\"container align-left\">\n\t\t\t\t\t\t\t\t<div class=\"carousel-caption\">\n\t\t\t\t\t\t\t\t\t<h2 class=\"visible text-start\">Acting with integrity and responsibility<\/h2>\n\t\t\t\t\t\t\t\t\t<div class=\"hidden text-start\"><\/div>\n\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\n\t\t\t\t\t\t\t\t\t<\/div>\n\n\t\t\t\t\n\t\t\t\t\t\t\t\t\t<div id=\"carouselButtons\" class=\"hidden visible\">\n\t\t\t\t\t\t<button id=\"playButton\" class=\"hidden\" aria-label=\"next\" aria-labelledby=\"playButton\" role=\"button\" type=\"button\" title=\"Play\"><\/button>\n\t\t\t\t\t\t<button id=\"pauseButton\" aria-label=\"next\" aria-labelledby=\"pauseButton\" role=\"button\" type=\"button\" title=\"Pause\"><\/button>\n\t\t\t\t\t<\/div>\n\t\t\t\t\n\t\t\t<\/div>\n\t\t<\/div>\n\t<\/section>\n\t<!-- Hero Carousel End Here-->\n  \n\n\t<!-- Ipsen Quotes Start -->\n\t<section class=\"quotes-section \">\n\t\t<div class=\"container\">\n\t\t\t\t\t\t<div class=\"quote-sec-inner\" style=\"background-image: url(https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/04\/19085624\/Group-252.png);\">\n\t\t\t\t\t<div class=\"row\">\n\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"column-1 col-xl-4 col-md-6 col-xs-12 \">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<div class=\"quote-img\">\n\t\t\t\t\t\t\t\t\t\t\t<img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2024\/10\/09125132\/Francois-GARNIER_Quote_446x360pix.png\" alt=\"Author Image\" title=\"Author Image\" >\n\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<div class=\"column-2 col-xl-8 col-md-6 col-xs-12 \">\n\t\t\t\t\t\t\t\t<div class=\"quote-content\">\n\t\t\t\t\t\t\t\t\t<div class=\"quote-para \">\n\t\t\t\t\t\t\t\t\t\t<p class=\"para charcoal-grey \">\n\t\t\t\t\t\t\t\t\t\t\t<p>Our governance approach emphasizes integrity and responsibility, prioritizing what\u2019s right over what\u2019s easy. Through our dedication to collaboration and ethical management, we consistently fulfill our promise to enhance lives with innovative healthcare solutions.<\/p>\n\t\t\t\t\t\t\t\t\t\t<\/p>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<div class=\"quote-sign-div\">\n\t\t\t\t\t\t\t\t\t\t<div class=\"quote-author-div\">\n\t\t\t\t\t\t\t\t\t\t\t<div class=\"quote-dash-div\">\n\t\t\t\t\t\t\t\t\t\t\t\t<span class=\"quote-dash\">\n\n\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<p class=\"quote-author primary-blue\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\tFran\u00e7ois Garnier\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/p>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<p class=\"quote-author-role charcoal-grey \">\n\t\t\t\t\t\t\t\t\t\t\t\t\tEVP, General Counsel and Chief Business Ethics Officer \t\t\t\t\t\t\t\t\t\t\t\t<\/p> \n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\t<\/div>\n<\/section>\n<!-- Ipsen Quotes End -->\n\n\n\n<!--Alert Card Layout Start Here-->\n<section class=\"alertcard-section\">\n      <div class=\"container\">\n        <!--Alert Box HTML Start Here-->\n        <div class=\"alert-box info-box\">\n                    <div class=\"info-icon\">\n              <span class=\"info-circle\"><img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/wp-content\/themes\/ipsen-main\/dist\/images\/alert-info-icon.png\" alt=\"Alert Icon\" title=\"Alert Icon\" \/><\/i>\n            <\/div>\n                    <div class=\"info-contents\">\n            <p class=\"info-head visible\">Upholding ethical standards for patients and society<\/p>\n            <p class=\"info-sub-head-para hidden\"><\/p>\n            <div class=\"alert-content visible\"><p>At Ipsen, we pride ourselves on our commitment to integrity, transparency and upholding the highest ethical standards. We are fostering responsible management while cultivating a strong ethical mindset that permeates every level of our organization.<\/p>\n<ul>\n<li>Doing what is right, not what is easy\u202f- delivering our results in an ethical and compliant manner, upholding human rights and anti-corruption, and an environment of integrity.<\/li>\n<li>Guided by our strategy: Focus. Together. For patients and society.\u202f Strong corporate governance, Sustainable targets in compensation, and Generation Ipsen program.<\/li>\n<li>Success delivered through responsible management \u2013 proactive risk management, and crisis management processes.<span data-contrast=\"none\">\u202f<\/span><span data-ccp-props=\"{}\">\u00a0<\/span><\/li>\n<\/ul>\n<\/div>\n          <\/div>\n        <\/div>\n        <!--Alert Box HTML Start Here-->\n      <\/div>\n    <\/section>\n<!--Alert Card Layout End Here-->\n\n\n<!-- Text & Media Block Code -->\n<section class=\"two-col-section text-media-section\">\n    <div class=\"container two-section-innner section-reverse\">\n        <div class=\"response-inner\" style=\"background-image: url('')\">\n            <div class=\"row section-reverse\">\n                <div class=\"col-xs-12 col-sm-12 col-md-6\">\n                                                    <div class=\"img-video-section\">\n                                <img decoding=\"async\" src=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2024\/06\/04105413\/Image1.png\" alt=\"Media Image\" title=\"Media Image\">\n                            <\/div>\n                                        <\/div>\n                <div class=\" col-xs-12 col-sm-12 col-md-6\">\n                    <div class=\"section-content\">\n                        <div class=\"heading-dash\">\n                                                    <\/div>\n                        <p class=\"section-head-two\">\n                            Ipsen\u2019s Code of Conduct                        <\/p>\n                        <p>Ipsen\u2019s Code of Conduct is a dynamic blueprint that emphasizes ethical decision-making, transparency and accountability across our diverse operations. This robust framework fuels an unwavering commitment to revolutionizing patient care, cultivating an empowering corporate culture, and exceeding industry standards and regulations.<\/p>\n                            \n                        <button aria-label=\"Learn more about Ipsen\u2019s Code of Conduct\" role=\"link\" class=\"btn-link section-btn cta-visible\"> \n                            <a aria-label=\"Learn more about\" href=\"https:\/\/d2rkmuse97gwnh.cloudfront.net\/a88aa6d6-3ca0-4362-a711-d53c45ae33ff\/2c1559af-6345-4db3-a985-ace41a30995e\/2c1559af-6345-4db3-a985-ace41a30995e_source__v.pdf\" target=\"_blank\"> Consult the full Code of Conduct <\/a>\n                        <\/button>\n                        \n                    <\/div>\n                <\/div>\n            <\/div>\n        <\/div>\n    <\/div>\n<\/section>\n\n\n\n\n    <section class=\"title-text img-bg\">\n        <div class=\"container\">\n            <div class=\"title-text-inner\" style=\"background-image:url(https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2024\/06\/20102116\/Ethics-transparency_1410x324.jpg)\">\n                <!-- If heading is enabled then it's visible -->\n                <div class=\"text-head-dash visible\">\n                                            <h2 class=\"heading-three\">\n                            Combating corruption with ethics and transparency                        <\/h2>\n                                        \n                <\/div>\n\n                <!-- If subtitle is enabled then it's visible -->\n                <div class=\"text-head-dash hidden\">\n                                            <h3 class=\"heading-three\">\n                                                    <\/h3>\n                    \n                <\/div>\n                \n                <!-- If description is enabled then it's visible -->\n                <div class=\"text-parbase visible\">\n                    <p><p>At Ipsen, we proudly uphold ethical standards, integrity and transparency in all of our endeavors. Robust anti-corruption policies ensure strict adherence to all applicable national and international legislation, accurate financial recordkeeping, and stakeholder interactions based on integrity and merit.<\/p>\n<\/p>\n                <\/div>\n\n                <!-- If button is enabled then it's visible -->\n                \n            <\/div>\n        <\/div>\n    <\/section>\n\n\n\n    <!--Accordion Cards Start Here-->\n    <section class=\"accordion\" data-according-id=\"1094738151\">\n        <div class=\"container\">\n            <div class=\"row\">\n                <!--Accordion info section-->\n                <div class=\"column-1 col-xl-12 col-md-12 col-sm-12\">\n                    <div class=\"accordian-info\">\n                        <h2 class=\"accordian-heading hidden\"><\/h3>\n                        <p class=\"accordian-summary hidden\"><\/p>\n                    <\/div>\n                <\/div><!--Accordion info section over here -->\n\n                <div class=\"col-xl-12 col-lg-12 col-md-12 col-sm-12\">\n                    <div class=\"accordion accor-group\" id=\"accordionExample1094738151\">\n                         \n                                    <!-- Accordion with Expandable panel & FAQs -->\n                                    <div class=\"accordion-item accor-item\">\n                                        <p class=\"accordion-header accor-head-para\" id=\"faqHeading0\">\n                                            <button class=\"accordion-button accor-faq-btn collapsed\" type=\"button\" data-bs-toggle=\"collapse\" data-bs-target=\"#faqHeading10947381510\" aria-expanded=\"true\" aria-controls=\"faqHeading10947381510\">\n                                                Anti-corruption at Ipsen                                            <\/button>\n                                        <\/p>\n                                        <div id=\"faqHeading10947381510\" class=\"accordion-collapse collapse \" aria-labelledby=\"faqHeading0\" data-bs-parent=\"#accordionExample1094738151\">\n                                            <div class=\"accordion-body\">\n                                                <div class=\"accordion-data\">\n                                                    <p><p>Fight corruption is a pledge in our Code of Conduct, as Ipsen rejects any form of corruption that distorts fair trade, hinders economic development, and imposes multiple costs on society at large.<\/p>\n<p>&nbsp;<\/p>\n<p>Ipsen\u2019s commitment to conducting business with high standards of ethics is reflected through the Anti-Corruption Program,\u00a0for a positive societal change under the Generation Ipsen. A dedicated cross-function operational committee works on meaningful anti-corruption initiatives and regularly reports to the Executive Leadership Team.<\/p>\n<p>&nbsp;<\/p>\n<p>Ipsen has been certified since 2021 to the ISO 37001- International Anti-Corruption Standard for anti-corruption management systems, for the benefit of Patients, Society and Employees.<\/p>\n<p>&nbsp;<\/p>\n<\/p>\n                                                    <div class=\"cta-block visible\" style=\"text-align:left;\">\n                                                                                                                        <a class=\"accr-cta-link\" href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/11150101\/Ipsen-ISO-37001-certification.pdf\" target=\"_blank\">Click for Certification<\/a>\n                                                                                                            <\/div>\n                                                <\/div>\n                                            <\/div>\n                                        <\/div>\n                                    <\/div>\n                             \n                                    <!-- Accordion with Expandable panel & FAQs -->\n                                    <div class=\"accordion-item accor-item\">\n                                        <p class=\"accordion-header accor-head-para\" id=\"faqHeading1\">\n                                            <button class=\"accordion-button accor-faq-btn collapsed\" type=\"button\" data-bs-toggle=\"collapse\" data-bs-target=\"#faqHeading10947381511\" aria-expanded=\"true\" aria-controls=\"faqHeading10947381511\">\n                                                Ipsen tax strategy and governance statement                                            <\/button>\n                                        <\/p>\n                                        <div id=\"faqHeading10947381511\" class=\"accordion-collapse collapse \" aria-labelledby=\"faqHeading1\" data-bs-parent=\"#accordionExample1094738151\">\n                                            <div class=\"accordion-body\">\n                                                <div class=\"accordion-data\">\n                                                    <p><p>Ipsen is a dynamic and growing global specialty-care biopharmaceutical group with a focus on transformative medicines in Oncology, Rare Disease and Neuroscience.<\/p>\n<p>In line with our sustainability framework, Generation Ipsen, we recognize our role as a responsible taxpayer to pay our full share of taxes, including corporate income taxes, as part of our contribution to society. \u00a0Thus, Ipsen pays its fair share of taxes in all countries where it operates.<\/p>\n<p>The aim of this document is to provide transparency to ensure a proper understanding of the way Ipsen approaches tax policy matters:<\/p>\n<ul>\n<li>Our compliance<\/li>\n<li>Our tax governance and risk management<\/li>\n<li>Our attitude to tax planning<\/li>\n<li>Our tax risks<\/li>\n<li>Our engagement with Tax Authorities<\/li>\n<\/ul>\n<p><strong>Our Compliance<\/strong><\/p>\n<p>&nbsp;<\/p>\n<p>The tax affairs are managed in a manner that is consistent within Ipsen\u2019s Code for Ethical conduct, to conduct business lawfully and ethically.<\/p>\n<p>Ipsen is committed to observing all applicable laws, rules and regulations in meeting its tax compliance and reporting responsibilities in all jurisdictions where it operates, and to ensuring compliance with all relevant legal disclosure requirements.<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Our tax governance and risk management<\/strong><\/p>\n<p>&nbsp;<\/p>\n<p>The fundamental objective of Ipsen\u2019s tax governance is to guarantee strict compliance and transparency with the applicable tax regulations and ensure adequate supervision of the tax policy implemented by its subsidiaries in all the territories where it operates.<\/p>\n<p>Ipsen applies diligent professional care and judgement, including ensuring that all decisions are taken at an appropriate level and are supported by consistent processes and guidelines and thorough documentation. The tax function is localized in France, UK and the US. The VP Group Tax department reports to the EVP CFO and our tax professionals are committed to the highest compliance standards in tax laws and regulations.<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Our attitude to tax planning<\/strong><\/p>\n<p>&nbsp;<\/p>\n<p>Ipsen\u2019s approach is to pay the correct and fair amount of tax to minimise the risk of uncertainty or disputes. Our tax positions are based on reasonable interpretation of applicable law and are aligned with the substance of the economic activity of our business locally.<\/p>\n<p>We are committed to maintain and follow a transfer pricing policy that is based on OECD Transfer Pricing Guidelines notably the arm\u2019s length standard and the goals of the OECD\/G20 Base Erosion and Profit Shifting project (\u201cBEPS\u201d).<\/p>\n<p>Ipsen has a zero-tolerance approach to tax evasion and the facilitation of tax evasion. Ipsen does not undertake aggressive tax planning or artificial tax arrangements. Where available, legitimate tax incentives (for example, R&amp;D tax credits) or exemptions are implemented in the spirit in which they are intended and aligned with our commercial business activities and reputation.<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Our tax risks<\/strong><\/p>\n<p>&nbsp;<\/p>\n<p>Ipsen seeks to comply fully with the tax regulations and actively manages its affairs to minimise the risk of non-compliance by ensuring that tax returns and payments are made on time with proper disclosure made to the tax authorities. We strive for full compliance and are continuously improving our processes, which are based on standardization, simplification and automation.<\/p>\n<p>Areas of uncertainty and complexity of current international tax law are managed by the Tax Department and, in addition, we regularly seek advice from independent external tax advisors to minimize our tax risk.<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Our engagement with the tax authorities<\/strong><\/p>\n<p>&nbsp;<\/p>\n<p>We seek to operate an honest and transparent relationship with all the tax authorities.<\/p>\n<p>We file timely and accurate tax returns, and we respond openly and promptly to any questions that may be raised in relation to our tax returns. Like any multinational company, our tax returns are continuously under audit around the world. In the event a tax authority disagrees with our views on the appropriate tax treatment of a given item, we will work constructively to try to resolve the issue in a timely manner through appropriate methods of dispute resolution.<\/p>\n<\/p>\n                                                    <div class=\"cta-block hidden\" >\n                                                                                                            <\/div>\n                                                <\/div>\n                                            <\/div>\n                                        <\/div>\n                                    <\/div>\n                             \n                                    <!-- Accordion with Expandable panel & FAQs -->\n                                    <div class=\"accordion-item accor-item\">\n                                        <p class=\"accordion-header accor-head-para\" id=\"faqHeading2\">\n                                            <button class=\"accordion-button accor-faq-btn collapsed\" type=\"button\" data-bs-toggle=\"collapse\" data-bs-target=\"#faqHeading10947381512\" aria-expanded=\"true\" aria-controls=\"faqHeading10947381512\">\n                                                Speak-Up &#038; Reporting Concerns                                            <\/button>\n                                        <\/p>\n                                        <div id=\"faqHeading10947381512\" class=\"accordion-collapse collapse \" aria-labelledby=\"faqHeading2\" data-bs-parent=\"#accordionExample1094738151\">\n                                            <div class=\"accordion-body\">\n                                                <div class=\"accordion-data\">\n                                                    <p><p>At Ipsen, we encourage employees to report potential non-compliant or unethical behaviors, fostering a speak-up culture and promoting transparency and accountability. Our Global Whistleblowing Policy is implemented since 2018.<\/p>\n<p>We commit to fairly addressing concerns that come to us. Report any concerns through the Whispli designated Alert Platform or use the email address <strong><a href=\"mailto: Ipsen.Ethics.Hotline@ipsen.com\">Ipsen.Ethics.Hotline@ipsen.com<\/a><\/strong>.<\/p>\n<\/p>\n                                                    <div class=\"cta-block hidden\" >\n                                                                                                            <\/div>\n                                                <\/div>\n                                            <\/div>\n                                        <\/div>\n                                    <\/div>\n                                                <\/div>\n                <\/div> \n            <\/div>\n        <\/div>\n    <\/section>\n    <!--Accordion Cards End Here-->\n\n\n\n    <!--Accordion Cards Start Here-->\n    <section class=\"accordion\" data-according-id=\"279571000\">\n        <div class=\"container\">\n            <div class=\"row\">\n                <!--Accordion info section-->\n                <div class=\"column-1 col-xl-12 col-md-12 col-sm-12\">\n                    <div class=\"accordian-info\">\n                        <h2 class=\"accordian-heading hidden\"><\/h3>\n                        <p class=\"accordian-summary hidden\"><\/p>\n                    <\/div>\n                <\/div><!--Accordion info section over here -->\n\n                <div class=\"col-xl-12 col-lg-12 col-md-12 col-sm-12\">\n                    <div class=\"accordion accor-group\" id=\"accordionExample279571000\">\n                         \n                                    <!-- Accordion with Expandable panel & FAQs -->\n                                    <div class=\"accordion-item accor-item\">\n                                        <p class=\"accordion-header accor-head-para\" id=\"expHeading0\">\n                                            <button class=\"accordion-button accor-btn collapsed\" type=\"button\" data-bs-toggle=\"collapse\" data-bs-target=\"#expHeading2795710000\" aria-expanded=\"true\" aria-controls=\"expHeading2795710000\">\n                                                Business ethics                                            <\/button>\n                                        <\/p>\n                                        <div id=\"expHeading2795710000\" class=\"accordion-collapse collapse \" aria-labelledby=\"expHeading0\" data-bs-parent=\"#accordionExample279571000\">\n                                            <div class=\"accordion-body\">\n                                                <div class=\"accordion-data\">\n                                                    <p><p>Ipsen continuously enhances its Business Ethics Program, backed by a robust infrastructure and governance system. By fostering a culture of ownership, accountability and mindful decision-making, we maintain a strong ethical foundation.<\/p>\n<\/p>\n                                                    <div class=\"cta-block hidden\" >\n                                                                                                            <\/div>\n                                                <\/div>\n                                            <\/div>\n                                        <\/div>\n                                    <\/div>\n                             \n                                    <!-- Accordion with Expandable panel & FAQs -->\n                                    <div class=\"accordion-item accor-item\">\n                                        <p class=\"accordion-header accor-head-para\" id=\"expHeading1\">\n                                            <button class=\"accordion-button accor-btn collapsed\" type=\"button\" data-bs-toggle=\"collapse\" data-bs-target=\"#expHeading2795710001\" aria-expanded=\"true\" aria-controls=\"expHeading2795710001\">\n                                                Opportunities and Risks Governance                                            <\/button>\n                                        <\/p>\n                                        <div id=\"expHeading2795710001\" class=\"accordion-collapse collapse \" aria-labelledby=\"expHeading1\" data-bs-parent=\"#accordionExample279571000\">\n                                            <div class=\"accordion-body\">\n                                                <div class=\"accordion-data\">\n                                                    <p><p>Ipsen is committed to ensuring a robust Opportunities and Risks Governance policy, with several strategic and operational committees actively working to identify, assess and address risks and opportunities.<\/p>\n<\/p>\n                                                    <div class=\"cta-block hidden\" >\n                                                                                                            <\/div>\n                                                <\/div>\n                                            <\/div>\n                                        <\/div>\n                                    <\/div>\n                             \n                                    <!-- Accordion with Expandable panel & FAQs -->\n                                    <div class=\"accordion-item accor-item\">\n                                        <p class=\"accordion-header accor-head-para\" id=\"expHeading2\">\n                                            <button class=\"accordion-button accor-btn collapsed\" type=\"button\" data-bs-toggle=\"collapse\" data-bs-target=\"#expHeading2795710002\" aria-expanded=\"true\" aria-controls=\"expHeading2795710002\">\n                                                Working with third parties                                            <\/button>\n                                        <\/p>\n                                        <div id=\"expHeading2795710002\" class=\"accordion-collapse collapse \" aria-labelledby=\"expHeading2\" data-bs-parent=\"#accordionExample279571000\">\n                                            <div class=\"accordion-body\">\n                                                <div class=\"accordion-data\">\n                                                    <p><p>Ipsen recognizes that its third parties play an important role in Ipsen\u2019s success and commitments. \u00a0Accordingly, we strive to conduct business with organizations who share Ipsen\u2019s commitment to ethical culture and operate in a socially and environmentally responsible manner.<\/p>\n<p>&nbsp;<\/p>\n<p>The <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2024\/06\/14172607\/Ipsen-Business-Partner-Code-of-Conduct-June-2024-English.pdf\" target=\"_blank\" rel=\"noopener\"><strong><u>Ipsen Business Partner Code of Conduct<\/u><\/strong><\/a><em>\u00a0<\/em>\u00a0documents principles and expectations for establishing and maintaining a business relationship with our third parties.<\/p>\n<ul>\n<li>Ipsen complies with international and national laws, regulations and codes that prohibit any form of corruption and avoids doing business with entities and\/or individuals that are subject to official trade and economic sanctions. Following a risk-based approach, our Global Third Party Program ensures that we work with trusted and reputable third parties, that reasonably operate in a socially and environmentally responsible manner.<\/li>\n<li>Ipsen also implemented a Supplier Risk Management process using a unified digital platform and engaging cross-functional risk experts to ensure potential suppliers meet our standards. This approach streamlines assessments and strengthens risk management throughout our organization.<\/li>\n<li>Ipsen is committed to high financial compliance standards and has implemented a <em>No PO No Pay<\/em> approach for a wide majority of spend. This means third parties must have a valid purchase order before starting work and submitting an invoice for payment. Based on the country the third parties will be delivering services or goods to, the purchase order terms and conditions may slightly differ. Please click below for the applicable Purchase Order Terms &amp; Conditions<em>. <\/em><strong><a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/06\/20130027\/UK-Terms-and-Conditions-of-Purchase.pdf\" target=\"_blank\" rel=\"noopener\">Purchase Order Terms and Conditions<\/a>\u00a0<\/strong><\/li>\n<li>We conduct supplier qualification and regular risk-based due diligence across our value chain, which involves ensuring that our expectations for human rights, among other topics such as anti-corruption and a sustainable environment, are addressed at the earliest stages of the third party engagement.<\/li>\n<\/ul>\n<\/p>\n                                                    <div class=\"cta-block hidden\" >\n                                                                                                            <\/div>\n                                                <\/div>\n                                            <\/div>\n                                        <\/div>\n                                    <\/div>\n                             \n                                    <!-- Accordion with Expandable panel & FAQs -->\n                                    <div class=\"accordion-item accor-item\">\n                                        <p class=\"accordion-header accor-head-para\" id=\"expHeading3\">\n                                            <button class=\"accordion-button accor-btn collapsed\" type=\"button\" data-bs-toggle=\"collapse\" data-bs-target=\"#expHeading2795710003\" aria-expanded=\"true\" aria-controls=\"expHeading2795710003\">\n                                                Data privacy                                            <\/button>\n                                        <\/p>\n                                        <div id=\"expHeading2795710003\" class=\"accordion-collapse collapse \" aria-labelledby=\"expHeading3\" data-bs-parent=\"#accordionExample279571000\">\n                                            <div class=\"accordion-body\">\n                                                <div class=\"accordion-data\">\n                                                    <p><p>At Ipsen, we care about protecting the personal data of all our stakeholders. We ensure that we only use personal data as necessary, that our use of that data is lawful and fair, that we keep data secure, and that we inform individuals about how we use their data. We manage privacy compliance at Ipsen through policies, procedures and training, and by fostering a strong culture of respect for privacy.<\/p>\n<\/p>\n                                                    <div class=\"cta-block hidden\" >\n                                                                                                            <\/div>\n                                                <\/div>\n                                            <\/div>\n                                        <\/div>\n                                    <\/div>\n                             \n                                    <!-- Accordion with Expandable panel & FAQs -->\n                                    <div class=\"accordion-item accor-item\">\n                                        <p class=\"accordion-header accor-head-para\" id=\"expHeading4\">\n                                            <button class=\"accordion-button accor-btn collapsed\" type=\"button\" data-bs-toggle=\"collapse\" data-bs-target=\"#expHeading2795710004\" aria-expanded=\"true\" aria-controls=\"expHeading2795710004\">\n                                                Working with HCPs and HCOs                                            <\/button>\n                                        <\/p>\n                                        <div id=\"expHeading2795710004\" class=\"accordion-collapse collapse \" aria-labelledby=\"expHeading4\" data-bs-parent=\"#accordionExample279571000\">\n                                            <div class=\"accordion-body\">\n                                                <div class=\"accordion-data\">\n                                                    <p><p>We are committed to fostering transparency and trust in all of our collaborations with healthcare professionals (HCPs) and healthcare organizations (HCOs). By openly disclosing information on transfers of value, clinical trials, scientific publications and interest representation activities, we ensure integrity and promote a strong ethical foundation across our interactions.<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Transparency rules and reports<\/strong><\/p>\n<ul>\n<li><strong><a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2024\/06\/25162242\/2024-Disclosure-Code-Self-certification-letter_signed.pdf\" target=\"_blank\" rel=\"noopener\">Ipsen self-certification letter<\/a><\/strong><\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p>Please follow the links to the countries to find the information about local Transparency rules and reports:<\/p>\n<p><strong>\u00a0<\/strong><\/p>\n<p><strong><a href=\"https:\/\/d1bml1vmyeu9v2.cloudfront.net\/germany\/uber-uns\/#verpflichtungen\" target=\"_blank\" rel=\"noopener\">Austria<\/a><\/strong><\/p>\n<p><strong>\u00a0<\/strong><\/p>\n<p><strong><a href=\"https:\/\/www.betransparent.be\/en\/\" target=\"_blank\" rel=\"noopener\">Belgium<\/a><\/strong><\/p>\n<p><strong>\u00a0<\/strong><\/p>\n<p><strong>Bulgaria<\/strong><\/p>\n<ul>\n<li>No transfer of value in 2018, 2019, 2021, 2022<\/li>\n<li>2020 EFPIA report in euro:\u00a0<a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15102741\/Bulgaria_2020-EFPIA-Report.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Bulgarian<\/strong><\/a><\/li>\n<li>2023 EFPIA report in lev: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2024\/06\/25162259\/BULGARIA_2023_EFPIA_Report.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Bulgarian<\/strong><\/a><\/li>\n<li>Methodological note: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2024\/06\/25162303\/BULGARIA_2023_Methodological_Note.pdf\" target=\"_blank\" rel=\"noopener\"><strong>English<\/strong><\/a><\/li>\n<\/ul>\n<p><strong>\u00a0<\/strong><\/p>\n<p><strong>Croatia<\/strong><\/p>\n<ul>\n<li>2017 EFPIA report in euro: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15102748\/Croatia_2017-EFPIA-report-EURO.pdf\" target=\"_blank\" rel=\"noopener\"><strong>English<\/strong><\/a><\/li>\n<li>2017 EFPIA report in kuna: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15102750\/Croatia_2017-EFPIA-report-KUNA.pdf\" target=\"_blank\" rel=\"noopener\"><strong>English<\/strong><\/a><\/li>\n<li>No transfer of value in 2018, 2019, 2020, 2021, 2022, 2023<\/li>\n<li>Methodological note:\u00a0<a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15102752\/Croatia_2021-Methodological-note.pdf\" target=\"_blank\" rel=\"noopener\"><strong>English<\/strong><\/a><\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><strong>Cyprus\u00a0<\/strong><\/p>\n<ul>\n<li>No Transfer of value in 2018, 2020, 2021, 2022<\/li>\n<li>2019 EFPIA report in euro:\u00a0<a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15102753\/Cyprus_2019-EFPIA-Report.pdf\" target=\"_blank\" rel=\"noopener\"><strong>English<\/strong><\/a><\/li>\n<li>2023 EFPIA report in euro: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2024\/06\/25162244\/Cyprus_2023_EFPIA_report_EN.xlsx\" target=\"_blank\" rel=\"noopener\"><strong>English<\/strong><\/a><\/li>\n<li>Methodological note:\u00a0<a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2024\/06\/25162245\/Cyprus_2023_Methodological_Note.pdf\" target=\"_blank\" rel=\"noopener\"><strong>English<\/strong><\/a><\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><a href=\"http:\/\/www.ipsen.cz\/\" target=\"_blank\" rel=\"noopener\"><strong>Czech Republic<\/strong><\/a><\/p>\n<p>&nbsp;<\/p>\n<p><a href=\"https:\/\/www.ipsennordic.com\/commitments\/transparency-in-relations-and-interests\/\" target=\"_blank\" rel=\"noopener\"><strong>Denmark<\/strong><\/a><\/p>\n<p><strong>\u00a0<\/strong><\/p>\n<p><strong>Estonia<\/strong><\/p>\n<ul>\n<li>2019 EFPIA report in euro: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15102801\/Esthonia_2019-EFPIA-report.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Estonian<\/strong><\/a><\/li>\n<li>2020 EFPIA report in euro: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15102803\/Esthonia_2020-EFPIA-report.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Estonian<\/strong><\/a><\/li>\n<li>2021 EFPIA report in euro: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15102805\/Esthonia_2021-EFPIA-report.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Estonian<\/strong><\/a><\/li>\n<li>2022 EFPIA report in euro: <strong><a href=\"https:\/\/wave-eu-west-1.s3.eu-west-1.amazonaws.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/sites\/3\/2023\/05\/31112404\/Estonia-2022_EFPIA-report_final.pdf\" target=\"_blank\" rel=\"noopener\">Estonian<\/a><\/strong><\/li>\n<li>2023 EFPIA report in euro: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2024\/05\/31101628\/Estonia-2023_EFPIA-report_final.xlsx\" target=\"_blank\" rel=\"noopener\"><strong>Estonian<\/strong><\/a><\/li>\n<li>Methodological note:\u00a0<a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2024\/05\/31101635\/Estonia_2023-Methodological-Note.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Estonian<\/strong><\/a><\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><a href=\"https:\/\/www.ipsennordic.com\/commitments\/transparency-in-relations-and-interests\/\" target=\"_blank\" rel=\"noopener\"><strong>Finland<\/strong><\/a><\/p>\n<p>&nbsp;<\/p>\n<p><a href=\"https:\/\/www.transparence.sante.gouv.fr\/flow\/main;jsessionid=D2DB6E8DBDE57CE7022620DEC69729B1?execution=e1s1\" target=\"_blank\" rel=\"noopener\"><strong>France<\/strong><\/a><\/p>\n<p>&nbsp;<\/p>\n<p><a href=\"https:\/\/ipsen-pharma.de\/verpflichtungen\/transparenz-und-vertrauen\/deutschland\/\" target=\"_blank\" rel=\"noopener\"><strong>Germany<\/strong><\/a><\/p>\n<p>&nbsp;<\/p>\n<p><strong>Greece<\/strong><\/p>\n<ul>\n<li>2019 EFPIA report in euro: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15102814\/Greece_2019-EFPIA-report.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Greek<\/strong><\/a><\/li>\n<li>2020 EFPIA report in euro: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15102817\/Greece_2020-EFPIA-report.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Greek<\/strong><\/a><\/li>\n<li>2021 EFPIA report in euro: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15102821\/Greece_2021-EFPIA-report.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Greek<\/strong><\/a><\/li>\n<li>2022 EFPIA report in euro: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/06\/21105733\/Greece_2022-EFPIA-report.xlsx\" target=\"_blank\" rel=\"noopener\"><strong>Greek<\/strong><\/a><\/li>\n<li>2023 EFPIA report in euro: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2024\/06\/25162305\/GREECE_2023_EFPIA-report_GR.xlsx\" target=\"_blank\" rel=\"noopener\"><strong>Greek<\/strong><\/a><\/li>\n<li>Methodological note:\u00a0<a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2024\/06\/25162307\/GREECE_2023_Methodological-note_GR.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Greek<\/strong><\/a><\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><strong>Hungary<\/strong><\/p>\n<ul>\n<li>2019 EFPIA report in forint: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15102832\/Hungary_2019-EFPIA-report.pdf\" target=\"_blank\" rel=\"noopener\"><strong>English<\/strong><\/a><\/li>\n<li>2020 EFPIA report in forint: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15102834\/Hungary_2020-EFPIA-report.pdf\" target=\"_blank\" rel=\"noopener\"><strong>English<\/strong><\/a><\/li>\n<li>2021 EFPIA report in forint: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15102839\/Hungary_2022-Methodological-note.pdf\" target=\"_blank\" rel=\"noopener\"><strong>English<\/strong><\/a><\/li>\n<li>2022 EFPIA repot in forint: <strong><a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/06\/21105733\/Hungary_2022-EFPIA-report.xlsx\" target=\"_blank\" rel=\"noopener\">Hungarian<\/a><\/strong><\/li>\n<li>2023 EFPIA repot in forint: <strong><a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2024\/06\/25162308\/Hungary_2023_EFPIA-report_HU.xlsx\" target=\"_blank\" rel=\"noopener\">Hungarian<\/a><\/strong><\/li>\n<li>Methodological note:\u00a0<a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2024\/06\/25162310\/Hungary_2023_Methodological_Note_EN.pdf\" target=\"_blank\" rel=\"noopener\"><strong>English<\/strong><\/a><\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><strong>Iceland<\/strong><\/p>\n<ul>\n<li>No Transfer of value in 2018, 2019, 2020, 2021, 2022, 2023<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><a href=\"https:\/\/www.transferofvalue.ie\/\" target=\"_blank\" rel=\"noopener\"><strong>Ireland<\/strong><\/a><\/p>\n<p>&nbsp;<\/p>\n<p><a href=\"https:\/\/d1bml1vmyeu9v2.cloudfront.net\/italy\/chi-siamo-2\/\" target=\"_blank\" rel=\"noopener\"><strong>Italy<\/strong><\/a><\/p>\n<p>&nbsp;<\/p>\n<p><a href=\"https:\/\/www.vi.gov.lv\/en\/statement-material-or-other-support-provided-associations-foundations-and-medical-treatment-institutions\" target=\"_blank\" rel=\"noopener\"><strong>Latvia<\/strong><\/a><\/p>\n<p>&nbsp;<\/p>\n<p><strong>Lithuania<\/strong><\/p>\n<ul>\n<li>2019 EFPIA report in euro: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15102854\/Lithuania_2019-EFPIA-report.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Lithuanian<\/strong><\/a><\/li>\n<li>2020 EFPIA report in euro: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15102855\/Lithuania_2020-EFPIA-report.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Lithuanian<\/strong><\/a><\/li>\n<li>2021 EFPIA report in euro: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15102857\/Lithuania_2021-EFPIA-report.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Lithuanian<\/strong><\/a><\/li>\n<li>2022 EFPIA report in euro: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/06\/12111100\/Lithuania_2022-EFPIA-report.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Lithuanian<\/strong><\/a><\/li>\n<li>2023 EFPIA report in euro: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2024\/06\/25162313\/Lithuania-_2023-EFPIA-Report_final.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Lithuanian<\/strong><\/a><\/li>\n<li>Methodological note:\u00a0<a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2024\/06\/25162316\/Lithuania_2023-Methodological-note.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Lithuanian<\/strong><\/a><\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><strong>Luxembourg<\/strong><\/p>\n<ul>\n<li>2019 EFPIA report in euro: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15102907\/Luxenbourg_2019-EFPIA-Report.pdf\" target=\"_blank\" rel=\"noopener\"><strong>English<\/strong><\/a><\/li>\n<li>No Transfer of value in 2020<\/li>\n<li>2021 EFPIA report in euro: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15102913\/Luxenbourg_2021-EFPIA-Report.pdf\" target=\"_blank\" rel=\"noopener\"><strong>English<\/strong><\/a><\/li>\n<li>2022 EFPIA report in euro: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/06\/12111456\/Luxenbourg_2022-EFPIA-Report.pdf\" target=\"_blank\" rel=\"noopener\"><strong>English<\/strong><\/a><\/li>\n<li>2023 EFPIA report in euro: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2024\/06\/25162317\/LUX_2023_EFPIA-Report-2023.xlsx\" target=\"_blank\" rel=\"noopener\"><strong>English<\/strong><\/a><\/li>\n<li>Methodological note:\u00a0<a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2024\/06\/25162254\/BELUX_2023_Methodological_Note.pdf\" target=\"_blank\" rel=\"noopener\"><strong>English<\/strong><\/a><\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><strong>Malta<\/strong><\/p>\n<ul>\n<li>No Transfer of value in 2018, 2019, 2020, 2021, 2022, 2023<\/li>\n<li>Methodological note:\u00a0<a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15102915\/Malta_2016-EFPIA-Report.pdf\" target=\"_blank\" rel=\"noopener\"><strong>English<\/strong><\/a><\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><a href=\"https:\/\/www.ipsennordic.com\/commitments\/transparency-in-relations-and-interests\/\"><strong>No<\/strong><\/a><a href=\"https:\/\/www.ipsennordic.com\/commitments\/transparency-in-relations-and-interests\/\" target=\"_blank\" rel=\"noopener\"><strong>rway<\/strong><\/a><\/p>\n<p>&nbsp;<\/p>\n<p><a href=\"https:\/\/d1bml1vmyeu9v2.cloudfront.net\/poland\/\" target=\"_blank\" rel=\"noopener\"><strong>Poland<\/strong><\/a><\/p>\n<p>&nbsp;<\/p>\n<p><a href=\"https:\/\/extranet.infarmed.pt\/pmro\/Publico\/ListagemPublica.aspx\" target=\"_blank\" rel=\"noopener\"><strong>Portugal<\/strong><\/a><\/p>\n<p>&nbsp;<\/p>\n<p><strong>Romania<\/strong><\/p>\n<ul>\n<li>2018 EFPIA report:\u00a0<a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15102926\/Romania_2018-EFPIA-report.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Romanian<\/strong><\/a>\/ Rapport R&amp;D 2018:\u00a0<a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15102929\/Romania_2018-Rapport.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Romanian<\/strong><\/a><\/li>\n<li>2019 EFPIA report:\u00a0<a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15102933\/Romania_2019-EFPIA-report.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Romanian<\/strong><\/a>\/ Rapport R&amp;D 2019:\u00a0<a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15102934\/Romania_2019-Rapport.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Romanian<\/strong><\/a><\/li>\n<li>2020 EFPIA report:\u00a0<a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15102938\/Romania_2020-EFPIA-report.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Romanian<\/strong><\/a>\/ Rapport R&amp;D 2020:\u00a0<a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15102940\/Romania_2020-Rapport.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Romanian<\/strong><\/a><\/li>\n<li>2021 EFPIA report:\u00a0<a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15102944\/Romania_2021-EFPIA-report.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Romanian<\/strong><\/a>\/ Rapport R&amp;D 2021:\u00a0<a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15102947\/Romania_2021-Rapport.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Romanian<\/strong><\/a><\/li>\n<li>2022 EFPIA report:\u00a0<a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15102950\/Romania_2022-EFPIA-report.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Romanian<\/strong><\/a>\/ Rapport R&amp;D 2022:\u00a0<a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15102952\/Romania_2022-Rapport.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Romanian<\/strong><\/a><\/li>\n<li>2023 EFPIA report: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2024\/04\/01120136\/Romania_2023_Transparency-report.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Romanian<\/strong><\/a>\/ Rapport R&amp;D 2023: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2024\/04\/01120122\/Romania_2023_RD-Report.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Romanian<\/strong><\/a><\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<ul>\n<li>2018 ANMDM Letter: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15102917\/Romania_2018-ANMDM.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Romanian<\/strong><\/a><\/li>\n<li>2019 ANMDM Letter: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15102931\/Romania_2019-ANMDM.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Romanian<\/strong><\/a><\/li>\n<li>2020 ANMDM Letter: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15102936\/Romania_2020-ANMDM.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Romanian<\/strong><\/a><\/li>\n<li>2021 ANMDM Letter: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15102941\/Romania_2021-ANMDM.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Romanian<\/strong><\/a><\/li>\n<li>2022 ANMDM Letter:\u00a0<a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15102948\/Romania_2022-ANMDM.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Romanian<\/strong><\/a><\/li>\n<li>2023 ANMDM Letter: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2024\/04\/01120118\/Romania_2023_ANMDM-Letter.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Romanian<\/strong><\/a><\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><a href=\"https:\/\/www.ipsen.com\/russia\/%d0%bf%d1%80%d0%be%d0%b7%d1%80%d0%b0%d1%87%d0%bd%d0%be%d1%81%d1%82%d1%8c-%d0%be%d1%82%d0%bd%d0%be%d1%88%d0%b5%d0%bd%d0%b8%d0%b9-%d1%81%d0%be-%d1%81%d0%bf%d0%b5%d1%86%d0%b8%d0%b0%d0%bb%d0%b8%d1%81\/\"><strong>R<\/strong><\/a><a href=\"https:\/\/www.ipsen.ru\/%D0%BE%D0%B1%D1%8F%D0%B7%D0%B0%D1%82%D0%B5%D0%BB%D1%8C%D1%81%D1%82%D0%B2%D0%B0\/%D0%BF%D1%80%D0%BE%D0%B7%D1%80%D0%B0%D1%87%D0%BD%D0%BE%D1%81%D1%82%D1%8C\/\" target=\"_blank\" rel=\"noopener\"><strong>ussia<\/strong><\/a><\/p>\n<p><strong>\u00a0<\/strong><\/p>\n<p><strong>Serbia<\/strong><\/p>\n<ul>\n<li>No Transfer of value in 2018, 2019<\/li>\n<li>2020 EFPIA report in euro: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15102954\/Serbia_2020-EFPIA-Report_EN.pdf\" target=\"_blank\" rel=\"noopener\"><strong>English<\/strong><\/a>\/\u00a0<a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15102955\/Serbia_2020-EFPIA-Report_RS.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Serbian<\/strong><\/a><\/li>\n<li>2021 EFPIA report in euro: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15102957\/Serbia_2021-EFPIA-Report.pdf\" target=\"_blank\" rel=\"noopener\"><strong>English<\/strong><\/a><\/li>\n<li>2022 EFPIA report in Serbian dinar: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/06\/12111825\/Serbia_2022-EFPIA-report.pdf\" target=\"_blank\" rel=\"noopener\"><strong>English<\/strong><\/a><\/li>\n<li>2023 EFPIA report in Serbian dinar: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2024\/06\/25162318\/SERBIA_2023_EFPIA-report.xlsx\" target=\"_blank\" rel=\"noopener\"><strong>English<\/strong><\/a><\/li>\n<li>Methodological note: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2024\/06\/25162320\/SERBIA_2023_Methodological_Note.pdf\" target=\"_blank\" rel=\"noopener\"><strong>English<\/strong><\/a><\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><a href=\"https:\/\/www.nczisk.sk\/Statisticke_vystupy\/Zverejnovanie_podla_zakona_liekoch_zdravotnickych_pomockach\/Sumarne_spravy_o_vydavkoch\/Pages\/default.aspx\" target=\"_blank\" rel=\"noopener\"><strong>Slovakia<\/strong><\/a><\/p>\n<ul>\n<li>Methodological note:\u00a0<strong><a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2024\/06\/25162248\/Slovakia_2023_Methodological_Note_SK.pdf\" target=\"_blank\" rel=\"noopener\">Slovak<\/a><\/strong><\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><strong>Slovenia<\/strong><\/p>\n<ul>\n<li>No transfer of value in 2018, 2019, 2020<\/li>\n<li>2021 EFPIA report in euro: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15103004\/Slovenia_2022-EFPIA-Report.pdf\" target=\"_blank\" rel=\"noopener\"><strong>English<\/strong><\/a><\/li>\n<li>2022 EFPIA report in euro: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/06\/12112218\/Slovenia_2022-EFPIA-report.pdf\" target=\"_blank\" rel=\"noopener\"><strong>English<\/strong><\/a><\/li>\n<li>2023 EFPIA report in euro: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2024\/06\/25162324\/SLOVENIA_2023_EFPIA_-report.xlsx\" target=\"_blank\" rel=\"noopener\"><strong>English<\/strong><\/a><\/li>\n<li>Methodological note:\u00a0<a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2024\/06\/25162326\/SLOVENIA_2023_Methodological_Note.pdf\" target=\"_blank\" rel=\"noopener\"><strong>English<\/strong><\/a><\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><a href=\"https:\/\/www.ipsen.com\/spain\/ipsen-espana\/\" target=\"_blank\" rel=\"noopener\"><strong>Spain<\/strong><\/a><\/p>\n<p>&nbsp;<\/p>\n<p><a href=\"https:\/\/www.ipsennordic.com\/commitments\/transparency-in-relations-and-interests\/\" target=\"_blank\" rel=\"noopener\"><strong>Swede<\/strong><\/a><a href=\"https:\/\/www.ipsennordic.com\/commitments\/transparency-in-relations-and-interests\/\"><strong>n<\/strong><\/a><\/p>\n<p>&nbsp;<\/p>\n<p><a href=\"https:\/\/ipsen-pharma.de\/verpflichtungen\/transparenz-und-vertrauen\/schweiz\/\" target=\"_blank\" rel=\"noopener\"><strong>Switzerland<\/strong><\/a><\/p>\n<p><strong>\u00a0<\/strong><\/p>\n<p><strong><a href=\"https:\/\/transparantieregister.nl\/home\" target=\"_blank\" rel=\"noopener\">The Netherlands<\/a><\/strong><\/p>\n<p><strong>\u00a0<\/strong><\/p>\n<p><strong>Ukraine<\/strong><\/p>\n<ul>\n<li>2018 EFPIA report in hryvnia:\u00a0<a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15103007\/Ukraine_2018-EFPIA-report.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Ukrainian<\/strong><\/a><\/li>\n<li>2019 EFPIA report in hryvnia:\u00a0<a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15103008\/Ukraine_2019-EFPIA-report.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Ukrainian<\/strong><\/a><\/li>\n<li>2020 EFPIA report in hryvnia: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15103010\/Ukraine_2020-EFPIA-report_EN.pdf\" target=\"_blank\" rel=\"noopener\"><strong>English<\/strong><\/a>\/\u00a0<a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15103011\/Ukraine_2020-EFPIA-report_UA.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Ukrainian<\/strong><\/a><\/li>\n<li>2023 EFPIA report in hryvnia: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2024\/06\/25162328\/UKRAINE_2023_EFPIA_APRaD_English.xlsx\" target=\"_blank\" rel=\"noopener\"><strong>English<\/strong><\/a>\/\u00a0<a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2024\/06\/25162329\/UKRAINE_2023_EFPIA_APRaD_Ukrainian.xlsx\" target=\"_blank\" rel=\"noopener\"><strong>Ukrainian<\/strong><\/a><\/li>\n<li>Methodological note:\u00a0<a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2024\/06\/25162331\/Ukraine_2023-Methodological-note_EN.pdf\" target=\"_blank\" rel=\"noopener\"><strong>English<\/strong><\/a>\/\u00a0<a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2024\/06\/25162251\/Ukraine_2023_Methodological-note_UKR.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Ukrainian<\/strong><\/a><\/li>\n<\/ul>\n<p><strong>United Kingdom\u00a0<\/strong><\/p>\n<ul>\n<li><a href=\"https:\/\/www.abpi.org.uk\/our-ethics\/disclosure-uk\/\" target=\"_blank\" rel=\"noopener\"><strong>ABPI platform<\/strong><\/a><\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<\/p>\n                                                    <div class=\"cta-block hidden\" >\n                                                                                                            <\/div>\n                                                <\/div>\n                                            <\/div>\n                                        <\/div>\n                                    <\/div>\n                             \n                                    <!-- Accordion with Expandable panel & FAQs -->\n                                    <div class=\"accordion-item accor-item\">\n                                        <p class=\"accordion-header accor-head-para\" id=\"expHeading5\">\n                                            <button class=\"accordion-button accor-btn collapsed\" type=\"button\" data-bs-toggle=\"collapse\" data-bs-target=\"#expHeading2795710005\" aria-expanded=\"true\" aria-controls=\"expHeading2795710005\">\n                                                Support to patients and patient organizations                                            <\/button>\n                                        <\/p>\n                                        <div id=\"expHeading2795710005\" class=\"accordion-collapse collapse \" aria-labelledby=\"expHeading5\" data-bs-parent=\"#accordionExample279571000\">\n                                            <div class=\"accordion-body\">\n                                                <div class=\"accordion-data\">\n                                                    <p><p>Ipsen actively collaborates with patient organizations to better understand and support patients\u2019 needs. Emphasizing transparency, we publicly disclose financial and non-financial support provided to these organizations in adherence to the EFPIA Code.<\/p>\n<p>&nbsp;<\/p>\n<p>Based on our dedication to transparency and under the EFPIA Patient Organizations Code, we make a list of patient organizations to which we provide financial support (grants, sponsorships, donations, etc. etc..) or significant non-financial support publicly available for viewing.<\/p>\n<p>&nbsp;<\/p>\n<ul>\n<li>Year 2023: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2024\/07\/23095405\/PO-disclosure-2023_27062024_Final_Update.pdf\" target=\"_blank\" rel=\"noopener\">European Countries<\/a><\/li>\n<li>Year 2022: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2024\/06\/27132201\/2022_PO-disclosure-_EFPIA-report_updated_June2024.pdf\" target=\"_blank\" rel=\"noopener\">European Countries<\/a><\/li>\n<li>Year 2021: <a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15085948\/2022-Ipsen_POs_Transparency_Year-2021_3006_EFPIA-1.pdf\" target=\"_blank\" rel=\"noopener\">European Countries<\/a><\/li>\n<li>Year 2020:\u00a0<a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15085944\/2021-Ipsen_POs_Transparency_Year-2020_1712_all-countries-except-EU.pdf\" target=\"_blank\" rel=\"noopener\">All countries except EU<\/a>\u00a0\/\u00a0<a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15085941\/2021-Ipsen_POs_Transparency_Year-2020_1008_EFPIA.pdf\" target=\"_blank\" rel=\"noopener\">European Countries<\/a><\/li>\n<li>Year 2019:\u00a0<a href=\"https:\/\/www.ipsen.com\/wp-admin\/upload.php?item=23562\" target=\"_blank\" rel=\"noopener\">All countries except EU<\/a>\u00a0\/\u00a0<a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15085936\/2020-Ipsen_POs_Transparency_Year-2019_1007_EFPIA.pdf\" target=\"_blank\" rel=\"noopener\">European Countries<\/a><\/li>\n<\/ul>\n<\/p>\n                                                    <div class=\"cta-block hidden\" >\n                                                                                                            <\/div>\n                                                <\/div>\n                                            <\/div>\n                                        <\/div>\n                                    <\/div>\n                             \n                                    <!-- Accordion with Expandable panel & FAQs -->\n                                    <div class=\"accordion-item accor-item\">\n                                        <p class=\"accordion-header accor-head-para\" id=\"expHeading6\">\n                                            <button class=\"accordion-button accor-btn collapsed\" type=\"button\" data-bs-toggle=\"collapse\" data-bs-target=\"#expHeading2795710006\" aria-expanded=\"true\" aria-controls=\"expHeading2795710006\">\n                                                Clinical data transparency                                            <\/button>\n                                        <\/p>\n                                        <div id=\"expHeading2795710006\" class=\"accordion-collapse collapse \" aria-labelledby=\"expHeading6\" data-bs-parent=\"#accordionExample279571000\">\n                                            <div class=\"accordion-body\">\n                                                <div class=\"accordion-data\">\n                                                    <p><p>Ipsen is committed to transparency in clinical research, providing readily accessible information to patients, healthcare professionals and researchers. Ipsen provides access to clinical data while ensuring patient anonymity and the protection of commercially confidential information. Our approach is aligned with the Pharmaceutical Research and Manufacturers of America (PhRMA) and the European Federation of Pharmaceutical Industries and Associations (EFPIA) Principles for Responsible Clinical Trial Data Sharing (efpia.eu), which came into force in January 2014.<\/p>\n<p>&nbsp;<\/p>\n<ul>\n<li><strong>Study Registration: <\/strong>Ipsen discloses study information by registering studies and posting technical study results summaries on global and national public study registries in compliance with regulatory requirements and global industry standards.<\/li>\n<li><strong>Access to Clinical Data:<\/strong> Ipsen shares clinical data such as patient-level data and study documents with qualified scientific and medical researchers upon request. We publish anonymized clinical reports on agencies\u2019 websites according to global and local legislations. We also collaborate with agencies and national competent authorities as necessary to allow access to documents containing information on our research.<\/li>\n<li><strong>Scientific Publication:<\/strong> Ipsen commits to submit for publication and\/or present results of clinical trials, whatever the outcome, in biomedical journals, and\/or at international congresses and at scientific meetings. Ipsen aims to provide open access to all Ipsen-affiliated research, ensuring free and unrestricted online availability of journal articles.<\/li>\n<li><strong>Lay\/Plain Language Summaries:<\/strong> Ipsen publishes study summaries and journal publication summaries in easily understandable language.<\/li>\n<\/ul>\n<p>Additional information on Ipsen Clinical Data Transparency is available when clicking on the below button.<\/p>\n<\/p>\n                                                    <div class=\"cta-block visible\" style=\"text-align:left;\">\n                                                                                                                    <a href=\"https:\/\/www.ipsen.com\/clinical-data-transparency\/\" target=\"_blank\">\n                                                                <button class=\"accr-cta-btn btn-link section-btn cta-visible\">\n                                                                    Learn more                                                                <\/button>\n                                                            <\/a>\n                                                                                                            <\/div>\n                                                <\/div>\n                                            <\/div>\n                                        <\/div>\n                                    <\/div>\n                             \n                                    <!-- Accordion with Expandable panel & FAQs -->\n                                    <div class=\"accordion-item accor-item\">\n                                        <p class=\"accordion-header accor-head-para\" id=\"expHeading7\">\n                                            <button class=\"accordion-button accor-btn collapsed\" type=\"button\" data-bs-toggle=\"collapse\" data-bs-target=\"#expHeading2795710007\" aria-expanded=\"true\" aria-controls=\"expHeading2795710007\">\n                                                Animal welfare                                            <\/button>\n                                        <\/p>\n                                        <div id=\"expHeading2795710007\" class=\"accordion-collapse collapse \" aria-labelledby=\"expHeading7\" data-bs-parent=\"#accordionExample279571000\">\n                                            <div class=\"accordion-body\">\n                                                <div class=\"accordion-data\">\n                                                    <p><p>Ipsen does not have internal animal research facilities. Although Ipsen outsources its animal testing, it has put in place an Animal Welfare governance body ensuring the appropriate treatment of animals. We are signatories of Gircor\u2019s \u201cFrench Charter for Transparency on the Use of Animals for Scientific and Regulatory Purposes,\u201d and actively pursue the 3Rs: reduction, refinement and replacement of animal experimentation.<\/p>\n<p>&nbsp;<\/p>\n<p>Patients and society are at the core of Ipsen\u2019s mission to improve lives and health outcomes. Biological and medical research are critical to continuously increasing scientific knowledge and improving human health. While animal studies continue to play an important role in the medical research process and in the development of treatments improving the quality of life of millions of people, it is our priority to meet the highest possible standards of animal welfare. That\u2019s why we are among the signatories of the \u201cFrench Charter for Transparency on the Use of Animals for Scientific and Regulatory Purposes\u201d developed by the GIRCOR.<\/p>\n<ul>\n<li><a class=\"cta cta--primary has-shadow\" href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15131119\/French-Transparency-Charter-Animals-for-Science.pdf\" target=\"_blank\" rel=\"noopener\"><span class=\"cta__label\">Download the Charter<\/span><\/a><\/li>\n<li><a href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2024\/01\/12165736\/Charte-de-transparence-rapport-2022-EN.pdf\" target=\"_blank\" rel=\"noopener\"><span class=\"cta__label\">Download the annual report 2022<\/span><\/a><\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p>Ipsen\u2019s Cell-Based Assay is now fully implemented for its DYSPORT<sup>\u00ae<\/sup>\u00a0products supplied to the U.S., Canada, E.U. and Switzerland.<\/p>\n<ul>\n<li><a class=\"cta cta--primary has-shadow\" href=\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/05\/15131117\/00-IAW-ONLINE-POSITION-STATEMENT_Ipsens-CBA-implementation-EN-2020-02-25.pdf\" target=\"_blank\" rel=\"noopener\"><span class=\"cta__label\">Download Ipsen\u2019s position statement on the Cell-Based Assay<\/span><\/a><\/li>\n<\/ul>\n<\/p>\n                                                    <div class=\"cta-block hidden\" >\n                                                                                                            <\/div>\n                                                <\/div>\n                                            <\/div>\n                                        <\/div>\n                                    <\/div>\n                             \n                                    <!-- Accordion with Expandable panel & FAQs -->\n                                    <div class=\"accordion-item accor-item\">\n                                        <p class=\"accordion-header accor-head-para\" id=\"expHeading8\">\n                                            <button class=\"accordion-button accor-btn collapsed\" type=\"button\" data-bs-toggle=\"collapse\" data-bs-target=\"#expHeading2795710008\" aria-expanded=\"true\" aria-controls=\"expHeading2795710008\">\n                                                Early access policy                                            <\/button>\n                                        <\/p>\n                                        <div id=\"expHeading2795710008\" class=\"accordion-collapse collapse \" aria-labelledby=\"expHeading8\" data-bs-parent=\"#accordionExample279571000\">\n                                            <div class=\"accordion-body\">\n                                                <div class=\"accordion-data\">\n                                                    <p><h5>Ipsen\u2019s vision is to be a leading global biopharmaceutical company focused on innovation and Specialty Care and our mission is to improve patients\u2019 lives through innovative new medicines<\/h5>\n<p>&nbsp;<\/p>\n<p>Ipsen commits to enable Early Access to patients to Ipsen medicines which are not yet approved by local Health Authorities, hence not yet available for prescription, when the Ipsen medicines is considered as eligible for Early Access.<\/p>\n<p>&nbsp;<\/p>\n<p><strong>What is \u201cEarly Access\u201d:<\/strong><\/p>\n<p>Ipsen defines \u201cEarly Access\u201d<sup>1<\/sup>\u00a0as access to:<\/p>\n<ol>\n<li>Unapproved medicine for the requested indication in the country where the request comes from<\/li>\n<li>For life-threatening or serious medical conditions<\/li>\n<li>Where there is no satisfactory alternative therapy available for the given medical condition<\/li>\n<li>Where there is no alternative option for the patient to participate in an ongoing clinical trial in the given indication<\/li>\n<li>Where the medicine has reasonable medical evidence of the positive balance of benefits\/risks in the given indication and the medicinal product has started the regulatory process of approval in the US and\/or the EU<\/li>\n<\/ol>\n<p>Early Access can only take place if it is allowed within the local laws, rules and regulations or specifically approved in writing by local authorities.<\/p>\n<p>&nbsp;<\/p>\n<p>The physician and the patient should discuss the expected benefits, known and potential unknown risks before seeking Early Access to a medicinal product.<\/p>\n<p>&nbsp;<\/p>\n<p>In some cases, Ipsen may set up a program designed to provide Early Access to several patients in defined countries.<\/p>\n<p>&nbsp;<\/p>\n<p>The list of Ipsen\u2019s Early Access Programs in the United States is available on\u00a0<a href=\"http:\/\/www.clinicaltrials.gov\/\" target=\"_blank\" rel=\"noopener\">www.clinicaltrials.gov<\/a>.<\/p>\n<h3><\/h3>\n<h5>Request for Early Access to an Ipsen medicine:<\/h5>\n<p>&nbsp;<\/p>\n<p><strong>Who can request Early Access?<\/strong><\/p>\n<p>Only qualified Physicians can make requests for Early Access to an Ipsen medicine once they have exhausted all other appropriate and available options to treat the medical condition of their patient, including enrollment in a clinical trial.<\/p>\n<p>&nbsp;<\/p>\n<p><strong>How can the Physician contact Ipsen and make a request?<\/strong><\/p>\n<p>Physicians can contact Ipsen and send a request for Early Access to:\u00a0<a href=\"mailto:GlobalMedInfo@ipsen.com\">GlobalMedInfo@ipsen.com<\/a><\/p>\n<p>&nbsp;<\/p>\n<p><strong>What will happen to the request?<\/strong><\/p>\n<p>When the request is received by Ipsen, Ipsen will send an acknowledgement of receipt of the request within 48 business hours. The request will be assessed by Ipsen medical affairs fairly, as promptly as possible and after a thorough discussion with the Physician as necessary.<\/p>\n<p>&nbsp;<\/p>\n<p>The decision will be based on at least the following criteria:<\/p>\n<ol>\n<li>The conditions for Early Access are met<\/li>\n<li>Patient\u2019s individual medical conditions<\/li>\n<li>Ipsen medicine availability<\/li>\n<li>Regulatory and health system environment where the request has come from (e.g. to make sure a Pharmacovigilance structure is in place)<\/li>\n<\/ol>\n<p>&nbsp;<\/p>\n<p><strong>What will happen if the request is approved?\u00a0<\/strong><\/p>\n<p>If the request for Early Access is approved by Ipsen, the Physician must collect and complete all necessary documents to comply with appropriate rules and regulations \u2013 as quickly as possible. Once collected, Ipsen will send the Physician the requested Ipsen medicine for Early Access to treat their patient.<\/p>\n<p>&nbsp;<\/p>\n<p>The physician must commit to the regulatory obligations including reporting of adverse events during the entirety of the Early Access.<\/p>\n<p>&nbsp;<\/p>\n<p><strong>What will happen if the request is not approved?<\/strong><\/p>\n<p>Ipsen is committed to Early Access but the company cannot guarantee approval and regrets that there are occasions where it is not appropriate for the company to provide Early Access to its medicine or where the request does not fall within the definition of Early Access. In these circumstances we commit to provide a timely response and clear rationale for the decision.<\/p>\n<p>&nbsp;<\/p>\n<p><sub><sup>1<\/sup><em>Other terms commonly used: Compassionate Use, Early Access, Expanded Access Program, Managed Access Program, Patient Access Program, Special Access Program, Scheme Access Program, Temporary Use Authorization and Pre-approval access.<\/em><\/sub><\/p>\n<\/p>\n                                                    <div class=\"cta-block hidden\" >\n                                                                                                            <\/div>\n                                                <\/div>\n                                            <\/div>\n                                        <\/div>\n                                    <\/div>\n                                                <\/div>\n                <\/div> \n            <\/div>\n        <\/div>\n    <\/section>\n    <!--Accordion Cards End Here-->\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":2,"featured_media":0,"parent":23,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-16489","page","type-page","status-publish","hentry","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Governance at Ipsen | Upholding Ethical Business Practices<\/title>\n<meta name=\"description\" content=\"Explore Ipsen\u2019s commitment to ethics and transparency, supported by our strong governance, responsible practices and anti-corruption initiatives.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ipsen.com\/sustainability\/governance\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Governance at Ipsen | Upholding Ethical Business Practices\" \/>\n<meta property=\"og:description\" content=\"Explore Ipsen\u2019s commitment to ethics and transparency, supported by our strong governance, responsible practices and anti-corruption initiatives.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ipsen.com\/sustainability\/governance\/\" \/>\n<meta property=\"og:site_name\" content=\"Global\" \/>\n<meta property=\"article:modified_time\" content=\"2024-11-15T08:56:53+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@ipsengroup\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.ipsen.com\/sustainability\/governance\/\",\"url\":\"https:\/\/www.ipsen.com\/sustainability\/governance\/\",\"name\":\"Governance at Ipsen | Upholding Ethical Business Practices\",\"isPartOf\":{\"@id\":\"https:\/\/www.ipsen.com\/#website\"},\"datePublished\":\"2023-04-24T05:47:29+00:00\",\"dateModified\":\"2024-11-15T08:56:53+00:00\",\"description\":\"Explore Ipsen\u2019s commitment to ethics and transparency, supported by our strong governance, responsible practices and anti-corruption initiatives.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.ipsen.com\/sustainability\/governance\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.ipsen.com\/sustainability\/governance\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.ipsen.com\/sustainability\/governance\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.ipsen.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sustainability\",\"item\":\"https:\/\/www.ipsen.com\/sustainability\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Governance\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.ipsen.com\/#website\",\"url\":\"https:\/\/www.ipsen.com\/\",\"name\":\"Global\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.ipsen.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.ipsen.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.ipsen.com\/#organization\",\"name\":\"IPSEN\",\"url\":\"https:\/\/www.ipsen.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.ipsen.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/12\/07162335\/Latest_Ipsen-logo_168x48.svg\",\"contentUrl\":\"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/12\/07162335\/Latest_Ipsen-logo_168x48.svg\",\"caption\":\"IPSEN\"},\"image\":{\"@id\":\"https:\/\/www.ipsen.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/Ipsengroup\",\"https:\/\/x.com\/ipsengroup\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Governance at Ipsen | Upholding Ethical Business Practices","description":"Explore Ipsen\u2019s commitment to ethics and transparency, supported by our strong governance, responsible practices and anti-corruption initiatives.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ipsen.com\/sustainability\/governance\/","og_locale":"en_US","og_type":"article","og_title":"Governance at Ipsen | Upholding Ethical Business Practices","og_description":"Explore Ipsen\u2019s commitment to ethics and transparency, supported by our strong governance, responsible practices and anti-corruption initiatives.","og_url":"https:\/\/www.ipsen.com\/sustainability\/governance\/","og_site_name":"Global","article_modified_time":"2024-11-15T08:56:53+00:00","twitter_card":"summary_large_image","twitter_site":"@ipsengroup","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.ipsen.com\/sustainability\/governance\/","url":"https:\/\/www.ipsen.com\/sustainability\/governance\/","name":"Governance at Ipsen | Upholding Ethical Business Practices","isPartOf":{"@id":"https:\/\/www.ipsen.com\/#website"},"datePublished":"2023-04-24T05:47:29+00:00","dateModified":"2024-11-15T08:56:53+00:00","description":"Explore Ipsen\u2019s commitment to ethics and transparency, supported by our strong governance, responsible practices and anti-corruption initiatives.","breadcrumb":{"@id":"https:\/\/www.ipsen.com\/sustainability\/governance\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ipsen.com\/sustainability\/governance\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.ipsen.com\/sustainability\/governance\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.ipsen.com\/"},{"@type":"ListItem","position":2,"name":"Sustainability","item":"https:\/\/www.ipsen.com\/sustainability\/"},{"@type":"ListItem","position":3,"name":"Governance"}]},{"@type":"WebSite","@id":"https:\/\/www.ipsen.com\/#website","url":"https:\/\/www.ipsen.com\/","name":"Global","description":"","publisher":{"@id":"https:\/\/www.ipsen.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ipsen.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.ipsen.com\/#organization","name":"IPSEN","url":"https:\/\/www.ipsen.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.ipsen.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/12\/07162335\/Latest_Ipsen-logo_168x48.svg","contentUrl":"https:\/\/www.ipsen.com\/websites\/ipsen_com_v2\/wp-content\/uploads\/2023\/12\/07162335\/Latest_Ipsen-logo_168x48.svg","caption":"IPSEN"},"image":{"@id":"https:\/\/www.ipsen.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Ipsengroup","https:\/\/x.com\/ipsengroup"]}]}},"_links":{"self":[{"href":"https:\/\/www.ipsen.com\/wp-json\/wp\/v2\/pages\/16489"}],"collection":[{"href":"https:\/\/www.ipsen.com\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.ipsen.com\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipsen.com\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipsen.com\/wp-json\/wp\/v2\/comments?post=16489"}],"version-history":[{"count":348,"href":"https:\/\/www.ipsen.com\/wp-json\/wp\/v2\/pages\/16489\/revisions"}],"predecessor-version":[{"id":69529,"href":"https:\/\/www.ipsen.com\/wp-json\/wp\/v2\/pages\/16489\/revisions\/69529"}],"up":[{"embeddable":true,"href":"https:\/\/www.ipsen.com\/wp-json\/wp\/v2\/pages\/23"}],"wp:attachment":[{"href":"https:\/\/www.ipsen.com\/wp-json\/wp\/v2\/media?parent=16489"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}